Hep Email Update
Can COVID-19 Testing Technologies Apply to Hepatitis C and Other Diseases?
Testing advances made during the COVID-19 pandemic may lead to “test and treat” approaches for hepatitis C. But there’s a holdup.
CVS to Help Engage Minority Populations in Clinical Trials

“Over 40% of the vulnerable population in the U.S. lives within five miles of a CVS Pharmacy location, so we have a chance to engage them.”

Multidrug Regimen Cures People With Hard-to-Treat Hepatitis
A four-drug combination cured all individuals who had experienced prior treatment failure. Over 16 to 24 weeks, all participants were successfully treated for hepatitis C.
Advertisement
What Is HBV?

Learn more about hepatitis B virus.

6 Facts About Hepatitis B
Check out this slideshow!
The Hep Magazine Archives

To read past issues of Hep, click the link!

Advertisement

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@hepmag.com. Please remember to add update@hepmag.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is:

Smart + Strong
157 Columbus Avenue, Suite 525
New York, NY 10023

Add us to your address book

Copyright (C) 2022 Smart + Strong 157 Columbus Avenue, Suite 525 New York, NY 10023 USA All rights reserved.
Terms Of Use and Your Privacy.